Post-marketing Safety Surveillance of NovoSeven® in Patients With Haemophilia and Inhibitors by Means of the UK Haemophilia Database

NCT00853086 · clinicaltrials.gov ↗

COMPLETED

Status

139

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Bleeding Disorder
Haemophilia A
Haemophilia B

Interventions

DRUG: activated recombinant human factor VII

Sponsor

Novo Nordisk A/S